Israel's Teva Pharmaceutical Industries Ltd.: Success with a Hybrid Business Model


Code :BSM0045

Year :

Industry : Health Care

Region : Israel

Teaching Note:Available

Structured Assignment :Available

Buy This Case Study

<< Previous

Big Pharma Companies vs Generic Drug Manufacturers: Divergently Convergent The global pharmaceutical industry sales were $712 billion in 2007. The industry is relatively fragmented and dominated by around a dozen big pharma companies. They derive competitive advantage through effective management of their value chain, the most important part of it being R&D...

Israel: A Hub of Research & Development? In a span of 60 years, Israel has been able to transform its economy from an agrarian one into a technology major. This transformation assumes greater significance as it was achieved under adverse circumstances. Since its inception in 1948, Israel has been subject to hostilities and disturbances and it had to constantly fight for its survival...

Teva - The Israeli Generic Drug Manufacturer Teva traces its origin to 1901, when a wholesale drug distributor by the name Salomon, Levin and Elstein Ltd. (SLE), based in Jerusalem was catering to the pharmaceutical needs of the people of the land which is today known to the world as Israel. In the 1930s, immigrants from central Europe, who included many scientists, technicians and chemists, set up small scale pharmaceutical manufacturing units in Israel. Some of them were Teva, Assia and Zori. In 1948, with the founding of Israel, there was mass immigration of scientists, technicians and chemists, which further boosted the local pharmaceutical industry...

For Case Books Click Here >>

For Case eBooks Click Here >>

Contact us: IBS Case Development Centre (IBSCDC), IFHE Campus, Donthanapally, Sankarapally Road, Hyderabad-501203, Telangana, INDIA.
Mob: +91- 9640901313,

2020-2025 IBS Case Development Centre. All rights reserved. | Careers | Privacy Policy | Terms of Use | Disclosure | Site Map xml sitemap